T-cell quality in memory and protection: Implications for vaccine design

Nature Reviews Immunology

Volumn 8, Issue 4, 2008, Pages 247-258

  Seder, Robert A ^a   Darrah, Patricia A ^a   Roederer, Mario ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; LEISHMANIA VACCINE; MALARIA VACCINE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR;

ANTIGEN SPECIFICITY; CD8+ T LYMPHOCYTE; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MALARIA; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINATION;

ANIMALS; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VACCINES;

EID: 41149096579     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2274     Document Type: Review

References (73)

1. Perfetto, S. P., Chattopadhyay, P. K. & Roederer, M. Seventeen-colour flow cytometry: unravelling the immune system. Nature Rev. Immunol. 4, 648-655 (2004). This article reviews the development and application of multiparameter flow cytometry for immunological assessments.
2. + T-cell responses in humans following an infection and suggest that multifunctional cells are beneficial.
3. + T lymphocytes with cellular maturation. J. Exp. Med. 203, 2865-2877 (2006).
4. H1 cells are correlated with protection and have enhanced effector function.
5. + T cell responses. J. Exp. Med. 204, 1405-1416 (2007).
6. + T cell responses in nonhuman primates. Proc. Natl Acad. Sci. USA 102, 15190-15194 (2005).
7. Kannanganat, S., Ibegbu, C., Chennareddi, L., Robinson, H. L. & Amara, R. R. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81, 8468-8476 (2007). This is the first study in humans to show that multifunctional T cells have increased MFI for IFNγ compared with all other populations.
8. EM cells in humans in response to infection with various viruses.
9. + T cells. Curr. Opin. Immunol. 15, 336-342 (2003).
10. H1 cells have differential capacities for memory cell generation in vivo. Nature Immunol. 3, 852-858 (2002).
11. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J. Immunol. 175, 5-14 (2005).
12. Harari, A., Petitpierre, S., Vallelian, F. & Pantaleo, G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103, 966-972 (2004).
13. + T cells endowed with proliferative capacity. J. Exp. Med. 198, 1909-1922 (2003).
14. Cooper, A. M. et al. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178, 2243-2247 (1993).
15. Flynn, J. L. et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254 (1993).
16. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367-1371 (1994).
17. Elias, D., Akuffo, H. & Britton, S. PPD induced in vitro interferon γ production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99, 363-368 (2005).
18. Pfeffer, K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 14, 185-191 (2003).
19. Skinner, M. A. et al. A DNA prime-live vaccine boost strategy in mice can augment IFN-γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Immunology 108, 548-555 (2003).
20. Blackwell, J. M. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112, S67-S74 (1996).
21. Bloom, B. R., Flynn, J., McDonough, K., Kress, Y. & Chan, J. Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection. Immunobiology 191, 526-536 (1994).
22. Bogdan, C., Moll, H., Solbach, W. & Rollinghoff, M. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20, 1131-1135 (1990).
23. Liew, F. Y., Li, Y. & Millott, S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145, 4306-4310 (1990).
24. Chan, J., Xing, Y., Magliozzo, R. S. & Bloom, B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175, 1111-1122 (1992).
25. + memory T cells. Immunol. Rev. 211, 146-153 (2006).
26. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65-78 (2003).
27. + T cells. Science 270, 1811-1815 (1995).
28. + T-cell responses by CD154 expression. Nature Protoc. 1, 1-6 (2006).
29. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunol. 3, 1061-1068 (2002).
30. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983-11991 (2001).
31. + T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165, 1082-1092 (2000).
32. + T cell responses associated with control of viremia. Science 278, 1447-1450 (1997).
33. + T cell proliferation. Proc. Natl Acad. Sci. USA 98, 13878-13883 (2001).
34. + T cells producing both interferon-γ and tumor necrosis factor-α. Blood 104, 487-494 (2004).
35. Zimmerli, S. C. et al. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl Acad. Sci. USA 102, 7239-7244 (2005).
36. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169, 6376-6385 (2002).
37. + T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176, 6973-6981 (2006).
38. + T helper cells in chronic HCV infection. Hepatology 41, 1019-1028 (2005).
39. Millington, K. A. et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178, 5217-5226 (2007).
40. + T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 107, 1427-1433 (2006).
41. Uzonna, J. E., Wei, G., Yurkowski, D. & Bretscher, P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167, 6967-6974 (2001).
42. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
43. + T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J. Virol. 81, 5460-5471 (2007).
44. + T lymphocytes. J. Immunol. 167, 181-187 (2001).
45. + memory T cells. Nature 441, 890-893 (2006).
46. + T cells. J. Exp. Med. 186, 757-766 (1997).
47. + memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 161, 5284-5295 (1998).
48. Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104-106 (1996).
49. + T cell responses: correlation of cytokine profile and TCR avidity. J. Immunol. 172, 5553-5560 (2004).
50. Wille-Reece, U. et al. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203, 1249-1258 (2006).
51. + T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J. Immunol. 177, 8185-8190 (2006).
52. Zaph, C., Uzonna, J., Beverley, S. M. & Scott, P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nature Med. 10, 1104-1110 (2004).
53. Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911-4927 (2003).
54. + T cells during viral infection: correlation with stable memory development. J. Gen. Virol. 83, 2123-2133 (2002).
55. Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225-234 (2003).
56. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
57. Harari, A., Vallelian, F. & Pantaleo, G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34, 3525-3533 (2004).
58. + effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 204, 2171-2185 (2007).
59. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169, 638-641 (2002).
60. + T cell lineage commitment. Nature Immunol. 6, 793-799 (2005).
61. + T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J. Immunol. 175, 4686-4696 (2005).
62. + T cells play a prominent role in recall responses to secondary viral infection in the lung. J. Immunol. 172, 6533-6537 (2004).
63. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nature Med. 11, 748-756 (2005).
64. + T cells. J. Exp. Med. 204, 2015-2021 (2007).
65. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007).
66. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. & Lanzavecchia, A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393 (2001).
67. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001).
68. De Rosa, S. C. et al. Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 173, 5372-5380 (2004). This paper demonstrates the use of multiparameter flow cytometry to identify and enumerate a broad range of antigen-specific T cells, and is the first to show simultaneous measurement of five functions on a cell-by-cell basis.
69. Harari, A. et al. An HIV-1 Clade C DNA Prime, NYVAC Boost Vaccine Regimen induces reliable, polyfunctional and long-lasting T cell responses. J. Exp. Med., 205, 63-77 (2008).
70. Shiver, J. W. et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335 (2002).
71. + memory T lymphocyte populations. Eur. J. Immunol. 37, 3089-3100 (2007).
72. Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nature Med. 9, 1131-1137 (2003).
73. + T cell differentiation during viral infection. Immunity 27, 393-405 (2007).